Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

Clinical trial NCT04930887 · RECRUITING

Trial details

NCT number: NCT04930887
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Craniofacial Pain Migraine Cluster Headache Trigeminal Autonomic Cephalgia Sphenopalatine Ganglion Neuralgia Paroxysmal Hemicrania

Start date: 2023-02-01
Primary completion: 2028-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.